Oddo BHF maintains its 'outperform' rating on Carbios shares, with a price target raised from 45 to 64 euros, believing that the latest advances are reassuring and give cause for optimism.

For the research firm, Carbios offers 'a disruptive enzymatic recycling solution for the plastic waste market'.

In this context, the exclusive partnership with Novozymes for the sale of enzymes, the partnership with world PET leader Indorama for the Longlaville plant, the receipt of government subsidies and the new strategic plan based on a premium licensing model mean that growth can be expected to accelerate over the next few years.

The analyst therefore raises his scenario: "Growth over the next few years is expected to be very strong, with estimated sales of 750 ME in 2035 and an EBITDA margin of 55%", concludes Oddo BHF.

Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.